This inventor holds 1 USPTO granted patent. Top assignee: Research Development Foundation. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Douglas E Vetter: Innovator in Anxiety Research
Introduction
Douglas E Vetter is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of anxiety research through his innovative work. His research focuses on the role of urocortin in anxiety-related behaviors and auditory physiology.
Latest Patents
Douglas E Vetter holds a patent for "Urocortin-deficient mice and uses thereof." This invention provides transgenic mice that are deficient in urocortin. The urocortin null mutant mice exhibit hypersensitivity to stress and display heightened anxiety-like behaviors in various tests. These mice also show physiological alterations in auditory thresholds and distortion product otoacoustic emissions. The findings suggest that urocortin plays a crucial role in modulating anxiety-related behaviors and in establishing auditory thresholds. Such urocortin-deficient mutant mice can serve as valuable models for studying anxiety pathology and hearing physiology at the biochemical and molecular levels. He has 1 patent to his name.
Career Highlights
Douglas E Vetter is associated with the Research Development Foundation, where he continues to advance his research. His work has implications for understanding anxiety disorders and auditory processing.
Collaborations
He has collaborated with notable colleagues, including Lingyun Zhao and Wylie Walker Vale, Jr. Their combined expertise contributes to the depth of research in the field.
Conclusion
Douglas E Vetter's innovative work in developing urocortin-deficient mice has opened new avenues for research in anxiety and auditory physiology. His contributions are significant in advancing our understanding of these complex areas.